KIR centromeric B haplotype is associated with significant risks of multiple basal cell carcinoma and squamous cell carcinoma, suggesting that interactions between KIRs and HLA molecules may modify the risks of basal cell carcinoma and squamous cell carcinoma (45). Here, KIR3DL1 is linked to squamous cell carcinoma.